Home LiteratureArticle Details
PMID: 18620057 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Review

The immune system and cardiac repair.

Pharmacological research ·Vol. 58 ·No. 2 ·2008-08-00 ·Pages 88-111

Frangogiannis NG

Abstract

Myocardial infarction is the most common cause of cardiac injury and results in acute loss of a large number of myocardial cells. Because the heart has negligible regenerative capacity, cardiomyocyte death triggers a reparative response that ultimately results in formation of a scar and is associated with dilative remodeling of the ventricle. Cardiac injury activates innate immune mechanisms initiating an inflammatory reaction. Toll-like receptor-mediated pathways, the complement cascade and reactive oxygen generation induce nuclear factor (NF)-kappaB activation and upregulate chemokine and cytokine synthesis in the infarcted heart. Chemokines stimulate the chemotactic recruitment of inflammatory leukocytes into the infarct, while cytokines promote adhesive interactions between leukocytes and endothelial cells, resulting in transmigration of inflammatory cells into the site of injury. Monocyte subsets play distinct roles in phagocytosis of dead cardiomyocytes and in granulation tissue formation through the release of growth factors. Clearance of dead cells and matrix debris may be essential for resolution of inflammation and transition into the reparative phase. Transforming growth factor (TGF)-beta plays a crucial role in cardiac repair by suppressing inflammation while promoting myofibroblast phenotypic modulation and extracellular matrix deposition. Myofibroblast proliferation and angiogenesis result in formation of highly vascularized granulation tissue. As the healing infarct matures, fibroblasts become apoptotic and a collagen-based matrix is formed, while many infarct neovessels acquire a muscular coat and uncoated vessels regress. Timely resolution of the inflammatory infiltrate and spatial containment of the inflammatory and reparative response into the infarcted area are essential for optimal infarct healing. Targeting inflammatory pathways following infarction may reduce cardiomyocyte injury and attenuate adverse remodeling. In addition, understanding the role of the immune system in cardiac repair is necessary in order to design optimal strategies for cardiac regeneration.

MeSH Terms
Animals Chemokines/physiology Complement System Proteins/physiology Cytokines Heart/physiology Humans Immune System/physiology Immunity, Innate Myocardial Infarction/immunology,pathology,physiopathology NF-kappa B/physiology Neutrophils/physiology Reactive Oxygen Species/metabolism Regeneration/physiology Signal Transduction
Chemicals
Chemokines Cytokines NF-kappa B Reactive Oxygen Species Complement System Proteins
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Frangogiannis Nikolaos G
Section of Cardiovascular Sciences, Baylor College of Medicine, One Baylor Plaza BCM620, Houston, TX 77030, United States. ngf@bcm.tmc.edu
References (358)
358 references, click to expand
  1. Making sense of latent TGFbeta activation.
    J Cell Sci. 2003 Jan 15;116(Pt 2):217-24 PMID: 12482908
  2. Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischaemia and at reperfusion.
    Cardiovasc Res. 2002 Mar;53(4):902-10 PMID: 11922900
  3. Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine.
    J Immunol. 1997 Dec 15;159(12):6216-25 PMID: 9550425
  4. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction.
    Circulation. 1994 May;89(5):1982-91 PMID: 8181121
  5. Smad-dependent and Smad-independent pathways in TGF-beta family signalling.
    Nature. 2003 Oct 9;425(6958):577-84 PMID: 14534577
  6. The mechanistic basis of infarct healing.
    Antioxid Redox Signal. 2006 Nov-Dec;8(11-12):1907-39 PMID: 17034340
  7. Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation.
    Crit Rev Clin Lab Sci. 2004;41(3):233-64 PMID: 15307633
  8. Biological activities of fibroblast growth factor-2 in the adult myocardium.
    Cardiovasc Res. 2003 Jan;57(1):8-19 PMID: 12504809
  9. Signaling factors in stem cell-mediated repair of infarcted myocardium.
    J Mol Cell Cardiol. 2005 Aug;39(2):363-76 PMID: 15992820
  10. Chymase inhibition prevents cardiac fibrosis and dysfunction after myocardial infarction in rats.
    Hypertens Res. 2006 Jan;29(1):57-64 PMID: 16715654
  11. Connective tissue growth factor and cardiac fibrosis after myocardial infarction.
    J Histochem Cytochem. 2005 Oct;53(10):1245-56 PMID: 15956033
  12. Extracellular matrix remodeling in canine and mouse myocardial infarcts.
    Cell Tissue Res. 2006 Jun;324(3):475-88 PMID: 16496177
  13. Oxidative stress and cardiac disease.
    Am J Med. 2000 Sep;109(4):315-23 PMID: 10996583
  14. Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation.
    Circ Res. 2004 Mar 19;94(5):601-8 PMID: 14752027
  15. Reactive oxygen species rapidly increase endothelial ICAM-1 ability to bind neutrophils without detectable upregulation.
    Blood. 1994 May 1;83(9):2669-77 PMID: 7513210
  16. L-selectin shedding regulates leukocyte recruitment.
    J Exp Med. 2001 Apr 2;193(7):863-72 PMID: 11283159
  17. Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities.
    J Biol Chem. 1991 Dec 5;266(34):23128-34 PMID: 1744111
  18. Age-associated impairment in TNF-alpha cardioprotection from myocardial infarction.
    Am J Physiol Heart Circ Physiol. 2003 Aug;285(2):H463-9 PMID: 12730063
  19. Molecular mechanisms of blood vessel growth.
    Cardiovasc Res. 2001 Feb 16;49(3):507-21 PMID: 11166264
  20. Regenerating the heart.
    Nat Biotechnol. 2005 Jul;23(7):845-56 PMID: 16003373
  21. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog.
    Circulation. 1983 May;67(5):1016-23 PMID: 6831665
  22. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes.
    Eur J Immunol. 1995 Jan;25(1):64-8 PMID: 7531149
  23. An anti-CD18 antibody limits infarct size and preserves left ventricular function in dogs with ischemia and 48-hour reperfusion.
    J Am Coll Cardiol. 1996 Apr;27(5):1278-85 PMID: 8609356
  24. Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury.
    Circulation. 1995 Oct 1;92(7):1866-75 PMID: 7671371
  25. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.
    J Clin Invest. 1993 Nov;92(5):2303-12 PMID: 8227345
  26. Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6.
    Am J Physiol. 1995 Aug;269(2 Pt 2):R229-35 PMID: 7544543
  27. Possible new role for NF-kappaB in the resolution of inflammation.
    Nat Med. 2001 Dec;7(12):1291-7 PMID: 11726968
  28. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4.
    J Biol Chem. 2004 Apr 23;279(17):17079-84 PMID: 14764599
  29. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction.
    Proc Natl Acad Sci U S A. 2000 May 9;97(10):5456-61 PMID: 10779546
  30. Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion.
    Circulation. 1998 Aug 18;98(7):699-710 PMID: 9715863
  31. Chemokines in the ischemic myocardium: from inflammation to fibrosis.
    Inflamm Res. 2004 Nov;53(11):585-95 PMID: 15693606
  32. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.
    J Cell Biol. 1988 May;106(5):1659-65 PMID: 2967299
  33. Early expression of angiogenesis factors in acute myocardial ischemia and infarction.
    N Engl J Med. 2000 Mar 2;342(9):626-33 PMID: 10699162
  34. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion.
    J Clin Invest. 1978 Mar;61(3):661-70 PMID: 641147
  35. Evolution of the lectin-complement pathway and its role in innate immunity.
    Nat Rev Immunol. 2002 May;2(5):346-53 PMID: 12033740
  36. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.
    Circulation. 1987 Jul;76(1):44-51 PMID: 3594774
  37. Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-alpha.
    J Am Coll Cardiol. 2002 Apr 3;39(7):1229-35 PMID: 11923051
  38. Interleukin-10.
    Annu Rev Immunol. 1993;11:165-90 PMID: 8386517
  39. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.
    J Clin Invest. 1998 Feb 15;101(4):890-8 PMID: 9466984
  40. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.
    Blood. 2000 Jul 1;96(1):34-40 PMID: 10891427
  41. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.
    J Clin Invest. 2004 Aug;114(3):438-46 PMID: 15286810
  42. Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1)1: SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction.
    Inflammation. 2001 Oct;25(5):293-300 PMID: 11820456
  43. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils.
    J Cell Biol. 1991 Feb;112(4):749-59 PMID: 1704376
  44. Role of interleukin-6 for LV remodeling and survival after experimental myocardial infarction.
    FASEB J. 2003 Nov;17(14):2118-20 PMID: 12958147
  45. Monocyte chemoattractant protein-1.
    Chem Immunol. 1999;72:7-29 PMID: 10550927
  46. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling.
    Cardiovasc Res. 2007 May 1;74(2):184-95 PMID: 17109837
  47. Bone marrow cells regenerate infarcted myocardium.
    Nature. 2001 Apr 5;410(6829):701-5 PMID: 11287958
  48. Tumor necrosis factor-alpha is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction.
    Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H743-53 PMID: 17416608
  49. Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarcts caused by 90 minutes of ischemia in dogs.
    Circulation. 1988 Aug;78(2):473-80 PMID: 3396182
  50. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease.
    Mol Med Today. 1996 May;2(5):198-204 PMID: 8796888
  51. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice.
    J Clin Invest. 1997 Mar 15;99(6):1340-50 PMID: 9077544
  52. Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia.
    Am J Pathol. 2001 Oct;159(4):1301-11 PMID: 11583958
  53. Oncostatin M differentially regulates CXC chemokines in mouse cardiac fibroblasts.
    Am J Physiol Cell Physiol. 2006 Jul;291(1):C18-26 PMID: 16452159
  54. Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1.
    J Clin Invest. 2000 Jan;105(1):101-11 PMID: 10619866
  55. Cardiotrophin-1: expression in experimental myocardial infarction and potential role in post-MI wound healing.
    Mol Cell Biochem. 2003 Dec;254(1-2):247-56 PMID: 14674704
  56. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury.
    Am J Physiol. 1988 Dec;255(6 Pt 2):H1269-75 PMID: 3059826
  57. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1.
    Circulation. 2001 Dec 11;104(24):2981-9 PMID: 11739316
  58. Leukocyte trans-endothelial migration: JAMs add new pieces to the puzzle.
    Thromb Haemost. 2003 Jan;89(1):13-7 PMID: 12540948
  59. Reperfusion injury is not affected by blockade of P-selectin in the diabetic mouse heart.
    Am J Physiol. 1999 Aug;277(2):H763-9 PMID: 10444504
  60. Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury.
    Circulation. 2000 Mar 7;101(9):1019-26 PMID: 10704170
  61. The role of contractile proteins in wound healing and fibrocontractive diseases.
    Methods Achiev Exp Pathol. 1979;9:187-206 PMID: 763158
  62. Introduction: functional polarity of motile neutrophils.
    Blood. 2000 Apr 15;95(8):2459-61 PMID: 10753821
  63. Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion.
    Circulation. 1997 Feb 4;95(3):701-8 PMID: 9024160
  64. Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deficient mice.
    Am J Physiol. 1998 Dec;275(6):H2300-7 PMID: 9843832
  65. Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction.
    J Mol Cell Cardiol. 2004 Apr;36(4):547-59 PMID: 15081314
  66. Targeting C-reactive protein for the treatment of cardiovascular disease.
    Nature. 2006 Apr 27;440(7088):1217-21 PMID: 16642000
  67. Ventricular arrhythmias in the acute and chronic phases after acute myocardial infarction. Effect of intervention with captopril.
    Circulation. 1994 Jul;90(1):101-7 PMID: 8025983
  68. Characterization of perceived hyperoxia in isolated primary cardiac fibroblasts and in the reoxygenated heart.
    J Biol Chem. 2003 Nov 21;278(47):47129-35 PMID: 12952964
  69. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium.
    Circulation. 1997 Feb 4;95(3):693-700 PMID: 9024159
  70. Mechanism of complement activation after coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo.
    Circ Res. 1988 Mar;62(3):572-84 PMID: 3257722
  71. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis.
    J Biol Chem. 1995 Nov 10;270(45):27348-57 PMID: 7592998
  72. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats.
    J Exp Med. 1971 Apr 1;133(4):885-900 PMID: 4993831
  73. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium.
    Nature. 2004 Apr 8;428(6983):668-73 PMID: 15034594
  74. Targeting complement in therapy.
    Immunol Rev. 2001 Apr;180:177-89 PMID: 11414360
  75. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling.
    Am J Pathol. 2008 Jul;173(1):57-67 PMID: 18535174
  76. IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury.
    J Immunol. 2000 Sep 1;165(5):2798-808 PMID: 10946312
  77. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction.
    FASEB J. 2007 Oct;21(12):3197-207 PMID: 17496162
  78. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses.
    Trends Immunol. 2002 Nov;23(11):509-12 PMID: 12401394
  79. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats.
    J Mol Cell Cardiol. 2001 Jun;33(6):1191-207 PMID: 11444923
  80. The liberation of CD44.
    J Cell Biol. 2003 Jun 9;161(5):839-43 PMID: 12796473
  81. The in vivo differentiation of human leukocytes into histiocytes, fibroblasts and fat cells in subcutaneous diffusion chambers.
    Blood. 1961 Jan;17:109-18 PMID: 13734879
  82. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice.
    Nat Med. 2000 May;6(5):556-63 PMID: 10802712
  83. Roles and relationship of macrophages and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the ischemic and reperfused rat heart.
    Lab Invest. 2000 Jul;80(7):1127-36 PMID: 10908159
  84. Emerging evidence for the role of cardiotrophin-1 in cardiac repair in the infarcted heart.
    Cardiovasc Res. 2005 Mar 1;65(4):782-92 PMID: 15721858
  85. Platelet activation leads to activation and propagation of the complement system.
    J Exp Med. 2005 Mar 21;201(6):871-9 PMID: 15781579
  86. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.
    Lancet. 2003 Aug 30;362(9385):697-703 PMID: 12957092
  87. Regulation of immune responses by TGF-beta.
    Annu Rev Immunol. 1998;16:137-61 PMID: 9597127
  88. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions.
    J Exp Med. 2007 Nov 26;204(12):3037-47 PMID: 18025128
  89. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis.
    Am J Physiol. 1996 May;270(5 Pt 2):H1803-11 PMID: 8928889
  90. Monocyte chemotactic protein 1 upregulates IL-1beta expression in human monocytes.
    Biochem Biophys Res Commun. 2000 Oct 14;277(1):37-42 PMID: 11027635
  91. Points of control in inflammation.
    Nature. 2002 Dec 19-26;420(6917):846-52 PMID: 12490957
  92. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes.
    J Clin Invest. 1995 Nov;96(5):2304-10 PMID: 7593617
  93. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair.
    Mol Med. 1994 Nov;1(1):71-81 PMID: 8790603
  94. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial.
    Circulation. 2003 Sep 9;108(10):1184-90 PMID: 12925454
  95. Mechanisms of neutrophil-induced parenchymal cell injury.
    J Leukoc Biol. 1997 Jun;61(6):647-53 PMID: 9201255
  96. Junctional adhesion molecule-A-deficient polymorphonuclear cells show reduced diapedesis in peritonitis and heart ischemia-reperfusion injury.
    Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10634-9 PMID: 16027360
  97. Role of complement in in vitro and in vivo lung inflammatory reactions.
    J Leukoc Biol. 1998 Jul;64(1):40-8 PMID: 9665273
  98. Cardiac mast cell-mediated activation of gelatinase and alteration of ventricular diastolic function.
    Am J Physiol Heart Circ Physiol. 2002 Jun;282(6):H2152-8 PMID: 12003823
  99. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo.
    J Clin Invest. 1995 Jan;95(1):89-103 PMID: 7814650
  100. MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy.
    Inflamm Allergy Drug Targets. 2007 Jun;6(2):101-7 PMID: 17692033
  101. Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis.
    Circulation. 2001 Sep 18;104(12 Suppl 1):I308-I3 PMID: 11568074
  102. Mechanisms of TGF-beta signaling from cell membrane to the nucleus.
    Cell. 2003 Jun 13;113(6):685-700 PMID: 12809600
  103. Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure.
    Circulation. 2005 May 17;111(19):2430-7 PMID: 15867170
  104. H2O2 and tumor necrosis factor-alpha induce differential binding of the redox-responsive transcription factors AP-1 and NF-kappaB to the interleukin-8 promoter in endothelial and epithelial cells.
    J Biol Chem. 1998 Dec 4;273(49):32670-8 PMID: 9830008
  105. Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta.
    J Immunol. 1999 May 1;162(9):5528-35 PMID: 10228034
  106. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: tryptase induces expression of mRNA for IL-1 beta and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells.
    J Immunol. 1998 Aug 15;161(4):1939-46 PMID: 9712064
  107. Effects of superoxide dismutase on reperfusion arrhythmias and left ventricular function in patients undergoing thrombolysis for anterior wall acute myocardial infarction.
    Am J Cardiol. 1991 Apr 1;67(8):765-7 PMID: 1900979
  108. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.
    Cell. 1989 Jul 28;58(2):227-9 PMID: 2665943
  109. CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction?
    Int Immunopharmacol. 2001 Mar;1(3):403-14 PMID: 11367525
  110. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting.
    J Mol Cell Cardiol. 2002 Feb;34(2):241-9 PMID: 11851363
  111. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1.
    J Exp Med. 1997 Jun 2;185(11):1959-68 PMID: 9166425
  112. Human heart generates complement proteins that are upregulated and activated after myocardial infarction.
    Circ Res. 1998 Oct 19;83(8):860-9 PMID: 9776733
  113. Soluble TNF receptors prevent apoptosis in infiltrating cells and promote ventricular rupture and remodeling after myocardial infarction.
    Cardiovasc Res. 2007 Mar 1;73(4):794-805 PMID: 17266945
  114. Blood monocytes consist of two principal subsets with distinct migratory properties.
    Immunity. 2003 Jul;19(1):71-82 PMID: 12871640
  115. Biologic basis for interleukin-1 in disease.
    Blood. 1996 Mar 15;87(6):2095-147 PMID: 8630372
  116. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling.
    Circulation. 2007 Nov 6;116(19):2127-38 PMID: 17967775
  117. The transforming growth factor-beta/Smad3 pathway: coming of age as a key participant in cardiac remodeling.
    Circulation. 2007 Nov 6;116(19):2096-8 PMID: 17984387
  118. Induction and suppression of interferon-inducible protein 10 in reperfused myocardial infarcts may regulate angiogenesis.
    FASEB J. 2001 Jun;15(8):1428-30 PMID: 11387246
  119. Granulocyte apoptosis and its role in the resolution and control of lung inflammation.
    Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 2):S5-11 PMID: 10556161
  120. Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology.
    Cytokine Growth Factor Rev. 2000 Mar-Jun;11(1-2):59-69 PMID: 10708953
  121. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS.
    Circulation. 2003 Oct 21;108(16):1912-6 PMID: 14568884
  122. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury.
    Circulation. 1989 Dec;80(6):1816-27 PMID: 2598440
  123. Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation.
    J Exp Med. 2003 Oct 20;198(8):1277-83 PMID: 14568985
  124. Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in postcapillary venules.
    J Clin Invest. 1994 Apr;93(4):1508-15 PMID: 7512982
  125. Dog mastocytoma cells produce transforming growth factor beta 1.
    J Clin Invest. 1992 Jul;90(1):35-41 PMID: 1634619
  126. Mobilized bone marrow cells repair the infarcted heart, improving function and survival.
    Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10344-9 PMID: 11504914
  127. Histochemical and morphological characteristics of canine cardiac mast cells.
    Histochem J. 1999 Apr;31(4):221-9 PMID: 10447063
  128. Mediation of cardioprotection by transforming growth factor-beta.
    Science. 1990 Jul 6;249(4964):61-4 PMID: 2164258
  129. Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction.
    Cardiovasc Res. 2004 Dec 1;64(3):526-35 PMID: 15537506
  130. In vivo transfer of soluble TNF-alpha receptor 1 gene improves cardiac function and reduces infarct size after myocardial infarction in rats.
    FASEB J. 2004 May;18(7):911-3 PMID: 15117889
  131. Leukocyte trafficking and myocardial reperfusion injury in ICAM-1/P-selectin-knockout mice.
    Am J Physiol Heart Circ Physiol. 2001 Jan;280(1):H60-7 PMID: 11123218
  132. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse.
    Development. 1999 Jun;126(14):3047-55 PMID: 10375497
  133. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta.
    J Cell Biol. 1986 Dec;103(6 Pt 1):2403-10 PMID: 3491081
  134. Activation of complement in normal serum by hydrogen peroxide and hydrogen peroxide-related oxygen radicals produced by activated neutrophils.
    Clin Exp Immunol. 1992 Oct;90(1):72-8 PMID: 1327592
  135. Signaling pathways involved in IL-8-dependent activation of adhesion through Mac-1.
    J Immunol. 2002 May 1;168(9):4559-66 PMID: 11971003
  136. Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide.
    Am J Pathol. 1984 Nov;117(2):201-6 PMID: 6388344
  137. The effect of thrombocytopenia on dermal wound healing.
    J Invest Dermatol. 2003 Jun;120(6):1130-7 PMID: 12787144
  138. Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction.
    J Am Coll Cardiol. 2008 Apr 8;51(14):1384-92 PMID: 18387441
  139. A chimeric IgG4 monoclonal antibody directed against CD18 reduces infarct size in a primate model of myocardial ischemia and reperfusion.
    J Am Coll Cardiol. 1995 Mar 1;25(3):781-8 PMID: 7860929
  140. Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8.
    J Clin Invest. 1995 Jun;95(6):2720-8 PMID: 7769111
  141. Concise review: stem cells, myocardial regeneration, and methodological artifacts.
    Stem Cells. 2007 Mar;25(3):589-601 PMID: 17124006
  142. NF-kappaB activation: the I kappaB kinase revealed?
    Cell. 1997 Oct 31;91(3):299-302 PMID: 9363938
  143. Mouse model of myocardial remodelling after ischemia: role of intercellular adhesion molecule-1.
    Cardiovasc Res. 2001 Feb 1;49(2):399-407 PMID: 11164850
  144. Resolution of lung inflammation by CD44.
    Science. 2002 Apr 5;296(5565):155-8 PMID: 11935029
  145. Opposing effects mediated by the chemokine receptor CXCR2 on myocardial ischemia-reperfusion injury: recruitment of potentially damaging neutrophils and direct myocardial protection.
    Circulation. 2003 Nov 11;108(19):2387-92 PMID: 14568904
  146. Cardiac-specific blockade of NF-kappaB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo.
    Am J Physiol Heart Circ Physiol. 2005 Jul;289(1):H466-76 PMID: 15695559
  147. Cardiac progenitor cells: the revolution continues.
    Circ Res. 2005 Nov 25;97(11):1080-2 PMID: 16306449
  148. Increased cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial infarction in the mouse; a potential role in cardiac dysfunction.
    Cardiovasc Res. 2003 Jul 1;59(1):122-31 PMID: 12829183
  149. The lack of cardiotrophin-1 alters expression of interleukin-6 and leukemia inhibitory factor mRNA but does not impair cardiac injury response.
    Cytokine. 2006 Oct;36(1-2):9-16 PMID: 17150369
  150. Morphological characteristics of the microvasculature in healing myocardial infarcts.
    J Histochem Cytochem. 2002 Jan;50(1):71-9 PMID: 11748296
  151. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure.
    Circulation. 2003 May 27;107(20):2555-8 PMID: 12742989
  152. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer.
    J Leukoc Biol. 1995 May;57(5):752-62 PMID: 7539029
  153. Role of interleukin-8 in neutrophil signaling.
    Curr Opin Hematol. 2000 May;7(3):178-82 PMID: 10786656
  154. Clinical applications of stem cells for the heart.
    Circ Res. 2005 Feb 4;96(2):151-63 PMID: 15692093
  155. Ischemia-reperfusion of rat myocardium activates nuclear factor-KappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine.
    Circulation. 2001 May 8;103(18):2296-302 PMID: 11342480
  156. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro.
    J Clin Invest. 1989 Jun;83(6):2008-17 PMID: 2566624
  157. New insights into the pathological role of TNF-alpha in early cardiac dysfunction and subsequent heart failure after infarction in rats.
    Am J Physiol Heart Circ Physiol. 2004 Jul;287(1):H340-50 PMID: 15210453
  158. Vascular mural cells in healing canine myocardial infarcts.
    J Histochem Cytochem. 2004 Aug;52(8):1019-29 PMID: 15258177
  159. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial.
    JAMA. 2007 Jan 3;297(1):43-51 PMID: 17200474
  160. Mast cells can secrete vascular permeability factor/ vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression.
    J Exp Med. 1998 Sep 21;188(6):1135-45 PMID: 9743532
  161. C1-esterase-inhibitor treatment at early reperfusion of hemorrhagic shock reduces mesentry leukocyte adhesion and rolling.
    Microcirculation. 2001 Dec;8(6):427-33 PMID: 11781815
  162. Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury.
    J Thorac Cardiovasc Surg. 1998 Jul;116(1):114-21 PMID: 9671905
  163. Senescent impairment in synergistic cytokine pathways that provide rapid cardioprotection in the rat heart.
    J Exp Med. 2004 Mar 15;199(6):797-804 PMID: 15007092
  164. Effect of propranolol on cardiac cytokine expression after myocardial infarction in rats.
    Mol Cell Biochem. 2003 Sep;251(1-2):127-37 PMID: 14575314
  165. Altered fibroblast function following myocardial infarction.
    J Mol Cell Cardiol. 2005 Oct;39(4):699-707 PMID: 16111700
  166. Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44.
    J Clin Invest. 1996 Oct 15;98(8):1713-27 PMID: 8878421
  167. Chemokines: a new classification system and their role in immunity.
    Immunity. 2000 Feb;12(2):121-7 PMID: 10714678
  168. Cytokine mRNA expression in postischemic/reperfused myocardium.
    Am J Pathol. 1995 Feb;146(2):419-28 PMID: 7856752
  169. NF-kappaB at the crossroads of life and death.
    Nat Immunol. 2002 Mar;3(3):221-7 PMID: 11875461
  170. The effect of CY1503, a sialyl Lewisx analog blocker of the selectin adhesion molecules, on infarct size and "no-reflow" in the rabbit model of acute myocardial infarction/reperfusion.
    J Mol Cell Cardiol. 1997 Aug;29(8):2013-25 PMID: 9281435
  171. Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10.
    Am J Respir Cell Mol Biol. 2004 Oct;31(4):395-404 PMID: 15205180
  172. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure.
    Circ Res. 2003 Feb 7;92(2):139-50 PMID: 12574141
  173. Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression.
    Am J Physiol Heart Circ Physiol. 2004 Sep;287(3):H1303-11 PMID: 15317679
  174. Cardioprotection initiated by reactive oxygen species is dependent on activation of PKCepsilon.
    Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1893-9 PMID: 16714357
  175. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
    J Am Coll Cardiol. 2006 Dec 5;48(11):2315-23 PMID: 17161265
  176. Negative inotropic effects of cytokines on the heart mediated by nitric oxide.
    Science. 1992 Jul 17;257(5068):387-9 PMID: 1631560
  177. Connective tissue and repair in the heart. Potential regulatory mechanisms.
    Ann N Y Acad Sci. 1995 Mar 27;752:286-99 PMID: 7755273
  178. Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo.
    FASEB J. 2005 Jan;19(1):1-11 PMID: 15629889
  179. Transforming growth factor-beta activation in irradiated murine mammary gland.
    J Clin Invest. 1994 Feb;93(2):892-9 PMID: 8113421
  180. Factors modifying protective effect of anti-CD18 antibodies on myocardial reperfusion injury in dogs.
    Am J Physiol. 1996 Jan;270(1 Pt 2):H53-64 PMID: 8769734
  181. Role of alpha4 integrin and VCAM-1 in CD18-independent neutrophil migration across mouse cardiac endothelium.
    Circ Res. 2002 Mar 22;90(5):562-9 PMID: 11909820
  182. Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options.
    Int J Cardiol. 1997 Jan 31;58(2):95-117 PMID: 9049675
  183. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury.
    Cardiovasc Res. 2004 Feb 15;61(3):481-97 PMID: 14962479
  184. Adhesion molecules and inflammatory injury.
    FASEB J. 1994 May;8(8):504-12 PMID: 8181668
  185. Interleukin-6 family of cytokines and gp130.
    Blood. 1995 Aug 15;86(4):1243-54 PMID: 7632928
  186. Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche.
    Nat Clin Pract Cardiovasc Med. 2007 Feb;4 Suppl 1:S21-6 PMID: 17230212
  187. Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death.
    J Mol Cell Cardiol. 2002 Feb;34(2):209-21 PMID: 11851360
  188. Platelets in inflammation and atherogenesis.
    J Clin Invest. 2005 Dec;115(12):3378-84 PMID: 16322783
  189. Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase.
    Circ Res. 1984 Mar;54(3):277-85 PMID: 6697450
  190. Chemokines--chemotactic cytokines that mediate inflammation.
    N Engl J Med. 1998 Feb 12;338(7):436-45 PMID: 9459648
  191. Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair.
    Am J Pathol. 2003 Dec;163(6):2433-40 PMID: 14633615
  192. Mechanisms of disease: Toll-like receptors in cardiovascular disease.
    Nat Clin Pract Cardiovasc Med. 2007 Aug;4(8):444-54 PMID: 17653117
  193. Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling.
    Circ Res. 2006 Sep 1;99(5):553-60 PMID: 16873716
  194. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.
    Lancet. 2004 Jul 10-16;364(9429):141-8 PMID: 15246726
  195. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury.
    J Clin Invest. 1993 Jun;91(6):2620-9 PMID: 7685773
  196. Cells in the circulating blood capable of producing connective tissue.
    Br J Exp Pathol. 1969 Feb;50(1):51-5 PMID: 5773146
  197. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis.
    Cardiovasc Res. 2000 May;46(2):257-63 PMID: 10773229
  198. Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion.
    J Clin Invest. 1991 Oct;88(4):1237-43 PMID: 1680879
  199. Effects of lodoxamide on ischemic reperfused myocardium.
    J Cardiovasc Pharmacol. 1982 May-Jun;4(3):441-8 PMID: 6177941
  200. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.
    Circulation. 1990 Apr;81(4):1161-72 PMID: 2138525
  201. Absence of NF-kappaB subunit p50 improves heart failure after myocardial infarction.
    FASEB J. 2006 Sep;20(11):1918-20 PMID: 16837548
  202. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection.
    Immunity. 2000 May;12(5):483-94 PMID: 10843381
  203. A blast from the past: clearance of apoptotic cells regulates immune responses.
    Nat Rev Immunol. 2002 Dec;2(12):965-75 PMID: 12461569
  204. Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor.
    Stem Cells. 2007 Jan;25(1):245-51 PMID: 17053210
  205. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium.
    J Clin Invest. 1999 Aug;104(3):271-80 PMID: 10430608
  206. Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling.
    Cardiovasc Res. 2007 May 1;74(2):313-22 PMID: 17188669
  207. Latency, activation, and binding proteins of TGF-beta.
    Microsc Res Tech. 2001 Feb 15;52(4):354-62 PMID: 11170294
  208. The cellular derivation and the life span of the myofibroblast.
    Pathol Res Pract. 1996 Jul;192(7):708-11 PMID: 8880871
  209. Platelets as immune cells: bridging inflammation and cardiovascular disease.
    Circ Res. 2007 Jan 5;100(1):27-40 PMID: 17204662
  210. Tumor necrosis factor-alpha contributes to ischemia- and reperfusion-induced endothelial activation in isolated hearts.
    Circ Res. 1999 Mar 5;84(4):392-400 PMID: 10066673
  211. Active interstitial remodeling: an important process in the hibernating human myocardium.
    J Am Coll Cardiol. 2002 May 1;39(9):1468-74 PMID: 11985909
  212. IKKbeta inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury.
    Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2248-53 PMID: 17675566
  213. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth.
    J Cell Mol Med. 2002 Jan-Mar;6(1):1-12 PMID: 12003665
  214. Regulation of collagen degradation in the rat myocardium after infarction.
    J Mol Cell Cardiol. 1995 Jun;27(6):1281-92 PMID: 8531210
  215. Recent advances in chemokines and chemokine receptors.
    Crit Rev Immunol. 1999;19(1):1-47 PMID: 9987599
  216. Collagen and myofibroblasts of granulation tissue. A chemical, ultrastructural and immunologic study.
    Virchows Arch B Cell Pathol. 1976 Aug 11;21(2):133-45 PMID: 822577
  217. Serum profiles of C-C chemokines in acute myocardial infarction: possible implication in postinfarction left ventricular remodeling.
    J Interferon Cytokine Res. 2002 Feb;22(2):223-9 PMID: 11911805
  218. CD44: from adhesion molecules to signalling regulators.
    Nat Rev Mol Cell Biol. 2003 Jan;4(1):33-45 PMID: 12511867
  219. Clinical epidemiology of acute myocardial infarction.
    Am Heart J. 1999 Aug;138(2 Pt 2):S48-54 PMID: 10426859
  220. Prevention of myocardial reperfusion injury in rats by an antibody against monocyte chemotactic and activating factor/monocyte chemoattractant protein-1.
    Lab Invest. 1999 Feb;79(2):195-203 PMID: 10068207
  221. Intracardiac fibroblasts, but not bone marrow derived cells, are the origin of myofibroblasts in myocardial infarct repair.
    Cardiovasc Pathol. 2005 Sep-Oct;14(5):241-6 PMID: 16168896
  222. Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat.
    J Mol Cell Cardiol. 2000 Oct;32(10):1821-30 PMID: 11013126
  223. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes.
    J Immunol. 1992 Apr 15;148(8):2423-8 PMID: 1348518
  224. Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion.
    Circulation. 1997 Feb 4;95(3):684-92 PMID: 9024158
  225. Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.
    J Am Coll Cardiol. 2000 Mar 1;35(3):569-82 PMID: 10716457
  226. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study.
    J Am Coll Cardiol. 2002 Oct 2;40(7):1199-204 PMID: 12383565
  227. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts.
    Circulation. 2005 Jun 7;111(22):2935-42 PMID: 15927970
  228. Cardioprotective actions of a monoclonal antibody against CD-18 in myocardial ischemia-reperfusion injury.
    Circulation. 1993 Oct;88(4 Pt 1):1779-87 PMID: 8104739
  229. Chemokines in ischemia and reperfusion.
    Thromb Haemost. 2007 May;97(5):738-47 PMID: 17479184
  230. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.
    J Biol Chem. 1986 Mar 25;261(9):4337-45 PMID: 3456347
  231. Unchain my heart: the scientific foundations of cardiac repair.
    J Clin Invest. 2005 Mar;115(3):572-83 PMID: 15765139
  232. Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb).
    Cardiovasc Res. 2000 Oct;48(1):89-100 PMID: 11033111
  233. Reactive oxygen species, cell signaling, and cell injury.
    Free Radic Biol Med. 2000 May 15;28(10):1456-62 PMID: 10927169
  234. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis.
    Cell. 1999 Feb 5;96(3):319-28 PMID: 10025398
  235. Wound healing. I. Injury and normal repair.
    N Engl J Med. 1958 Jul 31;259(5):224-33 PMID: 13566454
  236. Interleukin-18, a proinflammatory cytokine.
    Eur Cytokine Netw. 2000 Sep;11(3):483-6 PMID: 11203186
  237. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions.
    Circulation. 1999 Feb 2;99(4):546-51 PMID: 9927402
  238. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction.
    J Clin Invest. 1975 Sep;56(3):740-50 PMID: 808560
  239. A role for cardiac mast cells in the pathogenesis of hypertensive heart disease.
    J Hypertens. 2003 Oct;21(10):1935-44 PMID: 14508201
  240. Oxygen sensing by primary cardiac fibroblasts: a key role of p21(Waf1/Cip1/Sdi1).
    Circ Res. 2003 Feb 21;92(3):264-71 PMID: 12595337
  241. Structural remodeling of the infarcted rat heart.
    EXS. 1996;76:489-99 PMID: 8805814
  242. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma.
    Am J Pathol. 1995 Sep;147(3):564-73 PMID: 7545872
  243. Chemokines.
    Blood. 1997 Aug 1;90(3):909-28 PMID: 9242519
  244. Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction.
    Am J Pathol. 2004 Feb;164(2):665-77 PMID: 14742270
  245. Smad3 as a mediator of the fibrotic response.
    Int J Exp Pathol. 2004 Apr;85(2):47-64 PMID: 15154911
  246. Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro.
    Circ Res. 2000 Jun 23;86(12):1259-65 PMID: 10864917
  247. TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing.
    J Dermatol Sci. 2004 Aug;35(2):83-92 PMID: 15265520
  248. Oncostatin-M in myocardial ischemia/reperfusion injury may regulate tissue repair.
    Croat Med J. 2004 Apr;45(2):149-57 PMID: 15103750
  249. Deleterious effects of methylprednisolone in patients with myocardial infarction.
    Circulation. 1976 Mar;53(3 Suppl):I204-6 PMID: 1253361
  250. Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice.
    J Immunol. 2008 May 15;180(10):6954-61 PMID: 18453617
  251. Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction.
    Circulation. 2008 Feb 26;117(8):1055-64 PMID: 18268142
  252. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.
    Circulation. 1994 Jan;89(1):68-75 PMID: 8281697
  253. Circulating fibrocytes: collagen-secreting cells of the peripheral blood.
    Int J Biochem Cell Biol. 2004 Apr;36(4):598-606 PMID: 15010326
  254. Targeting the inflammatory response in healing myocardial infarcts.
    Curr Med Chem. 2006;13(16):1877-93 PMID: 16842199
  255. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation.
    J Clin Invest. 2002 Jan;109(1):41-50 PMID: 11781349
  256. Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion.
    Circulation. 1995 Jan 15;91(2):393-402 PMID: 7805243
  257. Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury.
    Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4556-60 PMID: 9539776
  258. Induction of nuclear factor kappaB and activation protein 1 in postischemic myocardium.
    FEBS Lett. 1997 Jan 13;401(1):30-4 PMID: 9003800
  259. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis.
    Science. 1990 Jul 13;249(4965):146-51 PMID: 2371562
  260. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice.
    FASEB J. 2000 Dec;14(15):2525-31 PMID: 11099471
  261. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts.
    J Cell Biol. 1993 Jul;122(1):103-11 PMID: 8314838
  262. Reciprocal regulation of angiopoietin-1 and angiopoietin-2 following myocardial infarction in the rat.
    Cardiovasc Res. 2004 Oct 1;64(1):115-24 PMID: 15364619
  263. Controversies in ventricular remodelling.
    Lancet. 2006 Jan 28;367(9507):356-67 PMID: 16443044
  264. Infarct scar: a dynamic tissue.
    Cardiovasc Res. 2000 May;46(2):250-6 PMID: 10773228
  265. Rate of collagen deposition during healing and ventricular remodeling after myocardial infarction in rat and dog models.
    Circulation. 1996 Jul 1;94(1):94-101 PMID: 8964124
  266. Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial.
    Circulation. 2003 Sep 9;108(10):1176-83 PMID: 12925455
  267. Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs.
    Circulation. 1987 Jun;75(6):1237-48 PMID: 3568330
  268. Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction.
    Circulation. 2004 Nov 16;110(20):3221-8 PMID: 15533863
  269. The role of neutrophils in myocardial ischemia-reperfusion injury.
    Cardiovasc Res. 1999 Sep;43(4):860-78 PMID: 10615413
  270. CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts.
    Circ Res. 2005 Apr 29;96(8):881-9 PMID: 15774854
  271. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury.
    J Pharmacol Exp Ther. 1998 Jul;286(1):429-38 PMID: 9655888
  272. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction.
    Circulation. 2003 Dec 9;108(23):2905-10 PMID: 14656915
  273. CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response.
    J Immunol. 2008 Feb 15;180(4):2625-33 PMID: 18250474
  274. Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts.
    Biochem Biophys Res Commun. 1999 Oct 22;264(2):561-7 PMID: 10529402
  275. Role of cardiac mast cells in complement C5a-induced myocardial ischemia.
    Am J Physiol. 1993 May;264(5 Pt 2):H1346-54 PMID: 7684573
  276. Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors.
    J Biol Chem. 1996 Jul 26;271(30):17779-84 PMID: 8663511
  277. Properties and functions of interleukin-10.
    Adv Immunol. 1994;56:1-26 PMID: 8073945
  278. Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction.
    Am J Pathol. 2004 Aug;165(2):439-47 PMID: 15277218
  279. Monoclonal antibodies to leukocyte integrins CD11a/CD18 and CD11b/CD18 or intercellular adhesion molecule-1 inhibit chemoattractant-stimulated neutrophil transendothelial migration in vitro.
    Blood. 1991 Oct 15;78(8):2089-97 PMID: 1680499
  280. beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling.
    Circulation. 2000 May 2;101(17):2103-9 PMID: 10790354
  281. Myofibroblasts and mechano-regulation of connective tissue remodelling.
    Nat Rev Mol Cell Biol. 2002 May;3(5):349-63 PMID: 11988769
  282. Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion.
    Circulation. 1998 Aug 18;98(7):687-98 PMID: 9715862
  283. Inflammatory cytokines and postmyocardial infarction remodeling.
    Circ Res. 2004 Jun 25;94(12):1543-53 PMID: 15217919
  284. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation.
    Int J Hematol. 2000 Dec;72(4):391-8 PMID: 11197203
  285. Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction.
    Mol Cell Biol. 1999 Apr;19(4):2495-504 PMID: 10082515
  286. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.
    Lancet. 2006 Jan 14;367(9505):113-21 PMID: 16413875
  287. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice.
    Circulation. 2004 Feb 17;109(6):784-9 PMID: 14970116
  288. Proteolytic control of growth factor availability.
    APMIS. 1999 Jan;107(1):80-5 PMID: 10190283
  289. The alpha-smooth muscle actin-positive cells in healing human myocardial scars.
    Am J Pathol. 1994 Oct;145(4):868-75 PMID: 7943177
  290. The role of the thrombospondins in healing myocardial infarcts.
    Cardiovasc Hematol Agents Med Chem. 2007 Jan;5(1):21-7 PMID: 17266545
  291. In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction.
    Nat Med. 1997 Aug;3(8):894-9 PMID: 9256281
  292. Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats.
    Cardiovasc Res. 1999 Jan;41(1):65-76 PMID: 10325954
  293. Interleukin-8 as a macrophage-derived mediator of angiogenesis.
    Science. 1992 Dec 11;258(5089):1798-801 PMID: 1281554
  294. Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart.
    J Mol Cell Cardiol. 1998 Aug;30(8):1559-69 PMID: 9737942
  295. Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3.
    J Clin Immunol. 2008 Jan;28(1):1-13 PMID: 17828584
  296. IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity.
    J Cell Biol. 1999 Jul 12;146(1):243-54 PMID: 10402474
  297. Leukemia inhibitory factor enhances survival of cardiomyocytes and induces regeneration of myocardium after myocardial infarction.
    Circulation. 2003 Aug 12;108(6):748-53 PMID: 12860906
  298. Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction.
    Circulation. 2003 Dec 23;108(25):3075-8 PMID: 14676146
  299. Mast cell tryptase is a mitogen for cultured fibroblasts.
    J Clin Invest. 1991 Aug;88(2):493-9 PMID: 1864960
  300. Ventricular remodeling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: effects of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor blockade.
    Basic Res Cardiol. 1999 Aug;94(4):246-53 PMID: 10505424
  301. Left ventricular remodeling and ventricular arrhythmias after myocardial infarction.
    Circulation. 2003 May 27;107(20):2577-82 PMID: 12732606
  302. Chemokines and disease.
    Nat Immunol. 2001 Feb;2(2):108-15 PMID: 11175802
  303. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1.
    J Cell Biol. 1998 Aug 10;142(3):873-81 PMID: 9700173
  304. Role of oxidants in the signaling pathway of preconditioning.
    Antioxid Redox Signal. 2001 Feb;3(1):3-10 PMID: 11291597
  305. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction.
    J Exp Med. 1999 Dec 20;190(12):1733-40 PMID: 10601349
  306. Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury.
    Circ Res. 1992 Dec;71(6):1518-24 PMID: 1423944
  307. Therapeutic inhibition of the complement system.
    Pharmacol Rev. 1998 Mar;50(1):59-87 PMID: 9549758
  308. Antioxidant and redox regulation of gene transcription.
    FASEB J. 1996 May;10(7):709-20 PMID: 8635688
  309. Lymphocyte traffic control by chemokines.
    Nat Immunol. 2001 Feb;2(2):123-8 PMID: 11175804
  310. SMAD and p38 MAPK signaling pathways independently regulate alpha1(I) collagen gene expression in unstimulated and transforming growth factor-beta-stimulated hepatic stellate cells.
    J Biol Chem. 2005 Mar 18;280(11):10055-64 PMID: 15647278
  311. Transforming growth factor beta regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans.
    J Biol Chem. 1988 Feb 25;263(6):3039-45 PMID: 3422640
  312. Development of cell injury in sustained acute ischemia.
    Circulation. 1990 Sep;82(3 Suppl):II2-12 PMID: 2394018
  313. Inflammatory cells during wound repair: the good, the bad and the ugly.
    Trends Cell Biol. 2005 Nov;15(11):599-607 PMID: 16202600
  314. Ccr1 deficiency reduces inflammatory remodelling and preserves left ventricular function after myocardial infarction.
    J Cell Mol Med. 2008 Apr;12(2):496-506 PMID: 18088392
  315. Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction.
    J Am Coll Cardiol. 2001 Oct;38(4):1207-15 PMID: 11583905
  316. Differential chemokine receptor expression and function in human monocyte subpopulations.
    J Leukoc Biol. 2000 May;67(5):699-704 PMID: 10811011
  317. Cardiolipin-protein complexes and initiation of complement activation after coronary artery occlusion.
    Circ Res. 1994 Sep;75(3):546-55 PMID: 8062428
  318. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood.
    J Exp Med. 1997 Jan 6;185(1):111-20 PMID: 8996247
  319. Complement inhibitors in myocardial ischemia/reperfusion injury.
    Immunopharmacology. 1997 Dec;38(1-2):27-42 PMID: 9476112
  320. CD18 trials disappoint again.
    Nat Biotechnol. 2000 Aug;18(8):817-8 PMID: 10932141
  321. Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice.
    J Mol Cell Cardiol. 1998 Nov;30(11):2281-9 PMID: 9925365
  322. Differential regulation of interleukin-8 and intercellular adhesion molecule-1 by H2O2 and tumor necrosis factor-alpha in endothelial and epithelial cells.
    J Biol Chem. 1997 Dec 26;272(52):32910-8 PMID: 9407069
  323. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar.
    Am J Pathol. 1995 Jan;146(1):56-66 PMID: 7856739
  324. C1-esterase inhibitor in ischemia and reperfusion.
    Immunobiology. 2002 Sep;205(4-5):552-62 PMID: 12396015
  325. Integrins as dynamic regulators of vascular function.
    FASEB J. 1994 Sep;8(12):929-38 PMID: 7522194
  326. The neutrophilic leukocyte in wound repair a study with antineutrophil serum.
    J Clin Invest. 1972 Aug;51(8):2009-23 PMID: 5054460
  327. NF-kappaB: a key role in inflammatory diseases.
    J Clin Invest. 2001 Jan;107(1):7-11 PMID: 11134171
  328. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2.
    Circulation. 2001 Dec 18;104(25):3158-67 PMID: 11748117
  329. Monocyte chemoattractant protein-1 induces scavenger receptor expression and monocyte differentiation into foam cells.
    Biochem Biophys Res Commun. 2003 May 30;305(2):380-5 PMID: 12745086
  330. Oxygen, oxidative stress, hypoxia, and heart failure.
    J Clin Invest. 2005 Mar;115(3):500-8 PMID: 15765131
  331. Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity.
    Am J Physiol Heart Circ Physiol. 2002 Aug;283(2):H518-25 PMID: 12124196
  332. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis.
    J Clin Invest. 2004 Nov;114(9):1308-16 PMID: 15520863
  333. Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration.
    J Immunol. 1999 Nov 1;163(9):5029-38 PMID: 10528208
  334. Cytokines and the microcirculation in ischemia and reperfusion.
    J Mol Cell Cardiol. 1998 Dec;30(12):2567-76 PMID: 9990529
  335. The role of CXC chemokines as regulators of angiogenesis.
    Shock. 1995 Sep;4(3):155-60 PMID: 8574748
  336. Neutralization of interleukin-1beta in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling.
    J Am Coll Cardiol. 2001 Nov 1;38(5):1546-53 PMID: 11691538
  337. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes.
    Nat Med. 2005 Mar;11(3):305-11 PMID: 15723072
  338. Immobilized IL-8 triggers progressive activation of neutrophils rolling in vitro on P-selectin and intercellular adhesion molecule-1.
    J Immunol. 2001 Oct 1;167(7):4017-25 PMID: 11564821
  339. Molecular and cellular mechanisms of myocardial stunning.
    Physiol Rev. 1999 Apr;79(2):609-34 PMID: 10221990
  340. The role of interleukin-6 in the failing heart.
    Heart Fail Rev. 2001 Mar;6(2):95-103 PMID: 11309528
  341. The role of the chemokines in myocardial ischemia and reperfusion.
    Curr Vasc Pharmacol. 2004 Apr;2(2):163-74 PMID: 15320517
  342. Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts.
    J Pathol. 2005 Jan;205(1):102-11 PMID: 15586361
  343. MCSF expression is induced in healing myocardial infarcts and may regulate monocyte and endothelial cell phenotype.
    Am J Physiol Heart Circ Physiol. 2003 Aug;285(2):H483-92 PMID: 12689859
  344. Coronary endothelial P-selectin in pathogenesis of myocardial ischemia-reperfusion injury.
    Am J Physiol. 1998 Nov;275(5):H1865-72 PMID: 9815095
  345. Effects of histamine on collagen synthesis by cultured fibroblasts derived from guinea pig skin.
    Arch Dermatol Res. 1985;277(1):60-4 PMID: 3970588
  346. Structure-activity relationships of chemokines.
    J Leukoc Biol. 1995 May;57(5):703-11 PMID: 7759949
  347. Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium.
    Circulation. 1993 Aug;88(2):649-58 PMID: 7687936
  348. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host.
    Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7808-11 PMID: 12805561
  349. Clinician guide to angiogenesis.
    Circulation. 2003 Nov 25;108(21):2613-8 PMID: 14638526
  350. Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro.
    Am J Physiol Heart Circ Physiol. 2000 Dec;279(6):H3020-30 PMID: 11087260
  351. Transforming growth factor beta-1 in acute myocardial infarction in rats.
    Growth Factors. 1988;1(1):91-9 PMID: 3078566
  352. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor.
    EMBO J. 1987 Jul;6(7):1899-904 PMID: 2820711
  353. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice.
    Cell. 1997 Jun 27;89(7):1021-31 PMID: 9215625
  354. Bone marrow cell transfer in acute myocardial infarction.
    Nat Clin Pract Cardiovasc Med. 2006 Mar;3 Suppl 1:S69-72 PMID: 16501635
  355. Myocyte renewal and ventricular remodelling.
    Nature. 2002 Jan 10;415(6868):240-3 PMID: 11805849
  356. Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis.
    J Immunol. 1997 Mar 1;158(5):2310-7 PMID: 9036979
  357. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury.
    Kidney Int. 2005 May;67(5):1772-84 PMID: 15840024
  358. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.
    Nature. 2004 Apr 8;428(6983):664-8 PMID: 15034593
Article Info
Journal
Pharmacological research
Abbr.
Pharmacol Res
ISSN
1043-6618
Published
2008-08-00
Epub
2008-00-24
Pages
88-111
Language
English
Region
Netherlands
NLM ID
8907422
PMCID
PMC2642482
Subset
IM
Grants
NHLBI NIH HHS · R01 HL-76246 · United States
NHLBI NIH HHS · R01 HL076246-04 · United States
NHLBI NIH HHS · R01 HL076246 · United States
NHLBI NIH HHS · R01 HL-85440 · United States
NHLBI NIH HHS · R01 HL085440-01A2 · United States
NHLBI NIH HHS · R01 HL085440 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com